In this week’s Pharma Pulse, GEODIS’ cold chain expansion in the Midwest, a potential multi-billion dollar shift in cell therapy, and the White House’s new push for psychedelic mental health ...
Joydeep Ganguly evaluates 4IR tools, data strategy, and why end-to-end thinking will define pharma supply chain ...
Following his keynote address at LogiPharma Europe 2026, Nico Vandaele, professor of Operations Research & Operations ...
Risk concentrates at transfer points and the final mile, where multiple touchpoints, tight delivery windows, and site-specific requirements can rapidly convert routine moves into service failures.
Pharmaceutical cold chain logistics is entering a phase where data quality and decision speed matter as much as physical ...
A bonded CFS footprint in a major North American freight gateway supports faster customs processing and secure short-term stowage for in-transit pharmaceutical cargo. Dedicated temperature-controlled ...
Regulatory expectations increasingly demand evidence of in-transit control, emphasizing data integrity, auditability, and ...
Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion. The centerpiece of the ...